Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P Rivière1, F Zerbib1

  • 1Service d'Hépato-gastroentérologie et Oncologie digestive, Centre Médico-chirurgical Magellan, CHU de Bordeaux, 33600 Pessac, France.

La Revue De Medecine Interne
|July 18, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytotoxicity and virulence attributes of <i>Pseudomonas aeruginosa</i> isolates from case reports of patients with necrotizing pneumonia.

Respiratory medicine case reports·2025
Same author

Persistence of subcutaneous versus intravenous infliximab in a real-life cohort: A propensity-score matched comparative analysis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024
Same author

[Celiac disease].

La Revue de medecine interne·2023
Same author

Deep ulcers are associated with increased C-reactive protein in active ulcerative colitis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2023
Same author

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.

Journal of Crohn's & colitis·2022
Same author

How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.

Journal of Crohn's & colitis·2022
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
Same journal

Heart involvements in systemic sclerosis beyond pulmonary hypertension: From conduction, rhythm and function defects to coronary artery disease.

La Revue de medecine interne·2026
Same journal

[Acute intermittent porphyria: When diagnostic errance jeopardizes patient health].

La Revue de medecine interne·2026
Same journal

Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

La Revue de medecine interne·2026
See all related articles

Microscopic colitis, a cause of chronic watery diarrhea, often affects postmenopausal women and can be linked to medications. Budesonide is a key treatment, aiming for remission to improve quality of life.

Area of Science:

  • Gastroenterology
  • Internal Medicine

Background:

  • Microscopic colitis is a significant cause of chronic watery diarrhea, particularly in postmenopausal women.
  • Approximately 50% of cases are associated with medication side effects, including NSAIDs and PPIs.

Purpose of the Study:

  • To outline the diagnostic and management strategies for microscopic colitis.
  • To emphasize achieving clinical remission and improving patient quality of life.

Main Methods:

  • Diagnosis requires colonic biopsies from multiple locations.
  • Initial management involves avoiding iatrogenic factors and smoking, alongside symptomatic treatment for diarrhea.

Main Results:

  • Budesonide is the primary treatment for treatment failure or severe symptoms, with the goal of achieving clinical remission (less than 3 liquid stools/day).
Keywords:
Colite collagèneColite lymphocytaireColite microscopiqueCollagenous colitisLymphocytic colitisMicroscopic colitis

Related Experiment Videos

  • Diarrhea recurrence is common after budesonide treatment, often necessitating maintenance therapy.
  • Second-line therapies, including immunosuppressants, biologics, or surgery, are considered for refractory or intolerant cases.
  • Conclusions:

    • Effective management of microscopic colitis focuses on budesonide therapy for remission and quality of life improvement.
    • Recurrence is frequent, requiring potential maintenance or second-line treatments discussed in a multidisciplinary setting.